What is BofA Securities's price target for INO?

BofA Securities's latest stated price target for Inovio Pharmaceuticals Inc. (INO) is $2, from its action on Nov 1, 2022.

What is BofA Securities's rating on INO?

BofA Securities rates INO Underperform, a bearish rating, as of Nov 1, 2022.

When did BofA Securities last change its view on INO?

On Nov 1, 2022, BofA Securities downgrades to Underperform from Neutral, price target $2.

Analyst firms · BofA Securities · INO

BofA Securities INO price target and rating history

Inovio Pharmaceuticals Inc. (INO) · Health Care

BofA Securities rates Inovio Pharmaceuticals Inc. (INO) Underperform with a $2 price target, as of its latest action on Nov 1, 2022. It has published 3 rating actions on INO since September 2021, including 1 upgrade and 2 downgrades.

Current rating: Underperform
Price target: $2
Median target, all firms: Too few
Actions on INO: 3

BofA Securities price target on INO

BofA Securities price target on INO, each point a stated target, September 2021 to November 2022.

Every BofA Securities rating on INO

Nov 1, 2022
DowngradeBofA Securities downgrades to Underperform from Neutral, price target $2
Jan 21, 2022
UpgradeBofA Securities upgrades to Neutral from Underperform, price target $8 to $10
Sep 10, 2021
DowngradeBofA Securities downgrades to Underperform from Neutral, price target $9 to $8

How other firms rate INO

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
H.C. Wainwright	Buy	$5	Nov 2, 2026
Jefferies	Buy	$3	Aug 13, 2026

Questions about BofA Securities and INO

What is BofA Securities's price target for INO?: BofA Securities's latest stated price target for Inovio Pharmaceuticals Inc. (INO) is $2, from its action on Nov 1, 2022.
What is BofA Securities's rating on INO?: BofA Securities rates INO Underperform, a bearish rating, as of Nov 1, 2022.
When did BofA Securities last change its view on INO?: On Nov 1, 2022, BofA Securities downgrades to Underperform from Neutral, price target $2.

More INO rating histories

All BofA Securities ratings INO news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.